| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2014 | Ocular manifestations of patients receiving heart transplants: A single-center experience of 311 consecutive cases | Su C.-C.; Chen J.-W.; Chou N.-K.; Chen Y.-S.; Huang S.-C.; Chi N.-H.; SHOEI-SHEN WANG | Transplantation Proceedings | |||
| 2014 | Ocular manifestations of patients receiving heart transplants: A single-center experience of 311 consecutive cases | Su C.-C.; Chen J.-W.; Chou N.-K.; Chen Y.-S.; SHU-CHIEN HUANG ; Chi N.-H.; Wang S.-S. | Transplantation Proceedings | |||
| 2018 | On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study | Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; Wu Y.-W.; Li Y.-H.; Yeh H.-I.; Chen J.-W.; CHAU-CHUNG WU ; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators | Journal of the Formosan Medical Association | |||
| 2018 | On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease – The multi-center T-SPARCLE registry study | Ho L.-T.; Lin F.-J.; Tseng W.-K.; Yin W.-H.; YEN-WEN WU ; Li Y.-H.; Yeh H.-I.; Chen J.-W.; Wu C.-C.; the Taiwanese Secondary Prevention for Patients with AtheRosCLErotic Disease (T-SPARCLE) Registry Investigators | Journal of the Formosan Medical Association | |||
| 2017 | Optimal achieved blood pressure for patients with stable coronary artery disease | Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; Wu Y.-W.; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; CHAU-CHUNG WU ; Chen J.-W. | Scientific Reports | |||
| 2017 | Optimal achieved blood pressure for patients with stable coronary artery disease | Huang C.-C.; Leu H.-B.; Yin W.-H.; Tseng W.-K.; YEN-WEN WU ; Lin T.-H.; Yeh H.-I.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. | Scientific Reports | |||
| 2019 | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan | Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; CHAU-CHUNG WU ; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. | Journal of the Formosan Medical Association | |||
| 2020 | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan | Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; CHIH-YUAN WANG ; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. | Journal of the Formosan Medical Association | |||
| 2020 | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan | Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; YEN-WEN WU ; Hwang J.-J.; Lin J.-L. | Journal of the Formosan Medical Association | |||
| 2020 | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan | Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; LI-KAI TSAI ; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. | Journal of the Formosan Medical Association | |||
| 2020 | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan | Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; SUNG-CHUN TANG ; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. | Journal of the Formosan Medical Association | |||
| 2020 | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan | Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; CHO-KAI WU ; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; Hwang J.-J.; Lin J.-L. | Journal of the Formosan Medical Association | |||
| 2020 | A performance guide for major risk factors control in patients with atherosclerotic cardiovascular disease in Taiwan | Li Y.-H.; Chen J.-W.; Lin T.-H.; Wang Y.-C.; Wu C.-C.; Yeh H.-I.; Huang C.-C.; Chang K.-C.; Wu C.-K.; Chen P.-W.; Huang C.-W.; Chen Z.-C.; Chang W.-T.; Huang W.-C.; Wang C.-Y.; Lee M.-Y.; Chao A.-C.; Fu W.-R.; Tsai L.-K.; Tang S.-C.; Chan H.-L.; Yang Y.-C.; Wu Y.-W.; HWANG, JUEY-JEN ; Lin J.-L. | Journal of the Formosan Medical Association | |||
| 2013 | Pitavastatin and Atorvastatin Double-Blind Randomized ComPArative Study among HiGh-Risk Patients, Including ThOse with Type 2 Diabetes Mellitus, in Taiwan (PAPAGO-T Study) | Liu P.-Y.; Lin L.-Y.; HUNG-JU LIN ; Hsia C.-H.; Hung Y.-R.; Yeh H.-I.; Wu T.-C.; Chen J.-Y.; Chien K.-L.; Chen J.-W. | PLoS ONE | |||
| 2020 | Potential impacts of high-sensitivity creatine kinase-MB on long-term clinical outcomes in patients with stable coronary heart disease | YEN-WEN WU ; Ho S.K.; Tseng W.-K.; Yeh H.-I.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Wu C.-C.; Chen J.-W. | Scientific Reports | |||
| 2007 | Pravastatin induces thrombomodulin expression in TNFα-treated human aortic endothelial cells by inhibiting Rac1 and Cdc42 translocation and activity | Lin S.-J.; Chen Y.-H.; Lin F.-Y.; Hsieh L.-Y.; SHU-HUEI WANG ; Lin C.-Y.; Wang Y.-C.; Ku H.-H.; Chen J.-W.; Chen Y.-L. | Journal of Cellular Biochemistry | |||
| 2007 | Pravastatin induces thrombomodulin expression in TNFα-treated human aortic endothelial cells by inhibiting Rac1 and Cdc42 translocation and activity | Lin S.-J.; Chen Y.-H.; Lin F.-Y.; Hsieh L.-Y.; Wang S.-H.; Lin C.-Y.; Wang Y.-C.; Ku H.-H.; Chen J.-W.; YUH-LIEN CHEN | Journal of Cellular Biochemistry | |||
| 2018 | Probabilistic safety evaluation of a river bridge substructure against floods | Liao K.-W.; Kung W.-C.; Chen J.-W.; KUO-WEI LIAO | Proceedings of the Institution of Civil Engineers: Structures and Buildings |  | ||
| 2018 | The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease | Ho S.-K.; Wu Y.-W.; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; CHAU-CHUNG WU ; Chen J.-W. | Scientific Reports | |||
| 2018 | The prognostic significance of heart-type fatty acid binding protein in patients with stable coronary heart disease | Ho S.-K.; YEN-WEN WU ; Tseng W.-K.; Leu H.-B.; Yin W.-H.; Lin T.-H.; Chang K.-C.; Wang J.-H.; Yeh H.-I.; Wu C.-C.; Chen J.-W. | Scientific Reports |
